Novo Nordisk A/S
Insulin degludec in cardiovascular conditions
Last updated:
Abstract:
The present invention relates to insulin degludec for use in medicine.
Status:
Grant
Type:
Utility
Filling date:
28 Nov 2017
Issue date:
22 Mar 2022